1. Mda-7/IL-24 induces the differentiation of B cell lymphoma via activation of the P38 mitogen activated protein kinase signaling pathway
   Ming Ma et al, 2017 CrossRef
2. Low expression of Mda-7/IL-24 and high expression of C-myb in tumour tissues are predictors of poor prognosis for Burkitt lymphoma patients
   Ming Ma et al, 2018, Hematology CrossRef
3. null
   Mitchell E. Menezes et al, 2018 CrossRef
4. Recent insights into apoptosis and toxic autophagy: the roles of MDA-7/IL-24, a multidimensional anti-cancer therapeutic
   Luni Emdad et al, 2019, Seminars in Cancer Biology CrossRef
5. null
   Derek W. Edwardson et al, 2019 CrossRef
6. The clinical significance of Mda‑7/IL‑24 and C‑myb expression in tumor tissues of patients with diffuse large B cell lymphoma
   Ming Ma et al, 2018, Exp Ther Med CrossRef
7. SUMO-fusion and autoinduction-based combinatorial approach for enhanced production of bioactive human interleukin-24 in Escherichia coli
   Sana Tahir et al, 2020, Appl Microbiol Biotechnol CrossRef
8. RNA binding protein GNL3 up-regulates IL24 and PTN to promote the development of osteoarthritis
   Zhen Zhu et al, 2021, Life Sciences CrossRef
9. Mesenchymal Stem Cells Cultured in 3D System Inhibit Non-Small Cell Lung Cancer Cells through p38 MAPK and CXCR4/AKT Pathways by IL-24 Regulating
   F. Suo et al, 2021, Mol Biol CrossRef
10. Enhanced Cancer Therapy Using an Engineered Designer Cytokine Alone and in Combination With an Immune Checkpoint Inhibitor
    Anjan K. Pradhan et al, 2022, Front. Oncol. CrossRef